Imagin Molecular Company Profile

11:05 EDT 21st March 2018 | BioPortfolio

Imagin Molecular Corporation is dedicated to business opportunities in the nuclear medicine field with its primary focus in positron emission tomography (PET). PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders. Imagin Molecular is a publicly traded Delaware corporation on the OTCBB under the symbol IMGM. Imagin Molecular is a holding company actively engaged in businesses such as nuclear medicine device manufacturing, coronary artery disease reversal and prevention molecular imaging centers with hospital joint ventures. Currently Imagin Molecular is the parent of three wholly owned operating subsidiaries. 1. Imagin Nuclear Partners Imagin Nuclear Partners is a full-service joint venture molecular imaging partner that will own, operate and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment. Imagin Nuclear Partners specializes in using evidence based bioinformatics specifically positioned in the market to provide the maximal cost-effective benefit to the Company’s joint venture partner and community. Imagin Nuclear Partners currently operates a PET center within Beth Israel Hospital in New York. Imagin Nuclear Partners uses the Positron HZL-R cardiac specific imaging camera from Positron Corporation. Imagin Nuclear Partners was formed to provide PET and related technical and educational services to diagnose and treat patients with coronary artery disease and who are at risk of developing coronary heart disease. Corporation is headquartered in Niagara Falls, New York. 2. Positron Acquisition Corporation Positron Acquisition Corporation was formed for the sole purpose of holding securities in Positron Corporation ( that were acquired in conjunction with a share exchange with Imagin Diagnostic Centres of Canada. Positron Acquisition Corporation currently holds 70,400,000 common shares of Positron Corporation. Imagin Molecular Corporation acquired this position to add value to its portfolio of PET businesses. Positron's leading cardiac PET software and device provides the complete solution for Imagin Molecular Corporation’s CAD reversal and prevention centers plan. Positron Corporation’s superior technology combined with the most economic camera and expertise is the total solution for Imagin Molecular Corporation and any PET facility. 3. Cipher Multimedia, Inc. Cipher Multimedia is a new Media Marketing and Distribution Solution Company that provides a Distribution Solution for publishers of digital content. Cipher Multimedia will develop marketing campaigns that will assist Imagin, Positron Corporation and other companies market their products and will continue to provide publishers a distribution solution for digital content. Imagin Molecular Corporation is in the process of spinning this company off through a stock dividend to its shareholders.


104 W. Chestnut St. #315
United States of America


Phone: 630/371-5583
Fax: 630/371-5584

News Articles [487 Associated News Articles listed on BioPortfolio]

Imagin Medical Research Study Begins

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 22, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company"), as a follow-up to...

Global Molecular Diagnostic Testing Market 2016-2021 - Expected High Growth in Molecular ...

Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. Read more...

American Urological Association (AUA) Honors Imagin Medical Scientific Advisor

VANCOUVER, BC and BOSTON, MA--(Marketwired - February 13, 2018) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company"), announced today that the lead investigato...

Imagin Medical Scientific Advisor Attends Society of International Urology Meeting

VANCOUVER, BC and BOSTON, MA--(Marketwired - October 27, 2017) - Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that Roger J. Buckley, M.D., Chief ...

Imagin Medical Closing Second and Final Tranche of $1,000,000 Private Placement

VANCOUVER, BC and BOSTON, MA--(Marketwired - October 13, 2017) - Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced today that, further to its press release...

Imagin Medical Builds Momentum for 2018

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 09, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company") announced that cri...

Imagin Medical Recruits Senior Healthcare Industry CFO

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 15, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company") announced today th...

Molecular POC Market to Reach USD 510 Million by 2023

The molecular point-of-care market (POC), consisting of systems with molecular capability used in decentralized test environments, was worth an estimated...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Salsalate [Libertas Pharma, Inc.]

Salsalate Tablets, USP 500 and 750 mgRx Only

PubMed Articles [604 Associated PubMed Articles listed on BioPortfolio]

How Secondary and Tertiary Amide Moieties are Molecular Stations for Dibenzo-24-crown-8 in 2Rotaxane Molecular Shuttles?

Interlocked molecular machines like [2]rotaxanes are intriguing aesthetic molecules. The control of the localization of the macrocycle, which surrounds a molecular axle, along the thread leads to tran...

Prospects of molecular breeding in medical plants.

The molecular-assisted breeding, transgenic breeding and molecular designing breeding are three development directions of plant molecular breeding. Base on these three development directions, this pap...

UPAR targeted molecular imaging of cancers with small molecule-based probes.

Molecular imaging can allow the non-invasive characterization and measurement of biological and biochemical processes at the molecular and cellular levels in living subjects. The imaging of specific m...

The Art of Building Small: From Molecular Switches to Motors (Nobel Lecture).

A journey into the nano-world: The ability to design, use and control motor-like functions at the molecular level sets the stage for numerous dynamic molecular systems. In his Nobel Lecture, B. L. F...

Picky Hsp90-Every Game with Another Mate.

In this issue of Molecular Cell, Sahasrabudhe et al. (2017) present a dramatically renovated functional cycle for the molecular chaperone Hsp90, which stimulates re-thinking of the mechanism of this ...

Clinical Trials [1189 Associated Clinical Trials listed on BioPortfolio]

Multimodal Imaging in Central Serous Chorioretinopathy

This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive opti...

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.

In Vivo EGFR Molecular Classification

The investigators developed 18F-MPG as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...

Validation of a Molecular Prognostic Test for Eye Melanoma

Up to half of patients with ocular melanoma (also called iris, choroidal or uveal melanoma) develop metastasis. We have found that certain molecular features of the eye tumor can be detect...

Companies [833 Associated Companies listed on BioPortfolio]

Imagin Molecular Corporation

Imagin Molecular Corporation (IMGM) is a company dedicated to socially responsible issues. IMGM main areas of interest are focused on medical and environmental. IMGM through its s...

Imagin Molecular

Imagin Molecular Corporation is dedicated to business opportunities in the nuclear medicine field with its primary focus in positron emission tomography (PET). PET is an advanced medical diagnostic im...

ABT Molecular Imaging

ABT Molecular Imaging is a medical imaging company marketing its Generator, a production platform which produces unit doses of molecular imaging drugs for positron emission tomogr...

HTG Molecular Diagnostics

HTG Molecular Diagnostics is a leading provider of molecular-based solutions for gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic appli...

Natural Molecular Testing Corp.

Natural Molecular Testing Corporation (NMTC) is a privately-owned, high-complexity molecular testing facility. NMTC provides genetic testing services and resources for our clinica...

More Information about "Imagin Molecular" on BioPortfolio

We have published hundreds of Imagin Molecular news stories on BioPortfolio along with dozens of Imagin Molecular Clinical Trials and PubMed Articles about Imagin Molecular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Imagin Molecular Companies in our database. You can also find out about relevant Imagin Molecular Drugs and Medications on this site too.

Quick Search


Relevant Topics

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record